Maternal Fetal Medicine Resources for Healthcare Professionals
At Children's Hospital Colorado, we're committed to partnering with referring physicians to improve the quality of life for moms and their babies. Get the latest in maternal fetal medicine healthcare information and learn about innovation in our Colorado Fetal Care Center programs that can improve outcomes for your patients.
Research articles and summaries
Children's Colorado has partnered with Mayo Clinic to study the use of stem cell therapy for hypoplastic left heart syndrome (HLHS). Learn more about our first patient.
Researchers at Children’s Hospital Colorado are investigating the safety and feasibility of providing regenerative therapy for a rare congenital heart defect called hypoplastic left heart syndrome (HLHS).
- Infants diagnosed with hypoplastic left heart syndrome in utero
- Stem cell collection at birth; Glenn procedure at 3-6 months old
CDH diagnosis, evaluation and management
Approximately one in 3,000 pregnancies are affected by a congenital diaphragmatic hernia (CDH), a fetal abnormality that can result in pulmonary hyperplasia and pulmonary hypertension. In this video, Michael Zaretsky, MD, Medical Director of the Colorado Fetal Care Center at Children's Colorado, outlines the measures maternal fetal medicine specialists should take in evaluating and making a CDH diagnosis.
Charting Pediatrics is a weekly podcast for pediatric healthcare providers. In this series, specialists from Children's Hospital Colorado examine the latest treatments for the most common complaints in pediatric medicine. Listen and subscribe on Spotify, iTunes, Google Podcasts and Google Play.
In this episode, we explore the stigmatized topic of physician burnout with Jenny Reese, MD, Director of the Resilience Program at CU Anschutz. She shares her personal experience with burnout and offers valuable insights on what physician burnout is, its effects and how hospitals can reduce burnout by implementing preventative measures.
Maternal Fetal Medicine news
March 18, 2019
Cumulative evidence supports a causal association between tobacco use in pregnancy and intrauterine growth restriction, and a plausible association between smoking and low levels of maternal folic acid. Given this evidence, we conducted a double-blind, randomized clinical trial to determine the efficacy of higher-dose folic acid in preventing a reduction in fetal body size among infants of women who smoked tobacco cigarettes during pregnancy.
Journal of the American Heart Association
March 12, 2019
Evidence linking individual‐level maternal folic acid supplementation to offspring risk of congenital heart defects is lacking. We investigated whether folic acid supplementation in early pregnancy reduces offspring risk of heart defects in two large birth cohort studies.
September 27, 2018
In this AFFIRM study, researchers tested the premise that introduction of a reduced fetal movement (RFM), care package for pregnant women and clinicians that increased women's awareness of the need for prompt reporting of RFM and that standardized management, including timely delivery, would alter the incidence of stillbirth.